Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or long-term lung damage. That scarring creates an environment that suppresses nearby immune cells, so by the time a tumor takes hold, it's often already shielded from the immune…
Back to Science
Science
September 25, 2026 at 4:00 PM
Targeted nanoparticles reduce tumor scarring and enable immunotherapy response in mice
Phys.org
Excerpt from Phys.org.